Hjem › Blærecancer › Minnesota › Rochester
Blærecancer kliniske forsøg i Rochester, MN
12 studier for Blærecancer søger deltagere på steder i og omkring Rochester (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RekruttererFase 3
- Mayo Clinic in Rochester, Rochester
Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI Trial
RekruttererFase 4
- Mayo Clinic in Rochester, Rochester
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RekruttererFase 2
- Mayo Clinic in Rochester, Rochester
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RekruttererFase 1
- Mayo Clinic Rochester, Rochester
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruttererObservationsstudie
- Mayo Clinic (Rochester), Rochester
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
RekruttererFase 2
- Mayo Clinic Rochester, Rochester
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
RekruttererFase 2
- Mayo Clinic, Rochester
Exploration of HRQOL and Urinary Outcomes Following Partial Cystectomy
RekruttererObservationsstudie
- Mayo Clinic in Rochester, Rochester
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RekruttererFase 1/2
- Mayo Clinic, Rochester
Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers
RekruttererFase 2
- Mayo Clinic in Rochester, Rochester
Bladder Bank (a Prospective Banking Study)
RekruttererObservationsstudie
- Mayo Clinic in Rochester, Rochester
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
- Mayo Clinic, Rochester
Blærecancer forsøg i andre byer
- New York City, NY35 studier
- Nashville, TN31 studier
- Houston, TX31 studier
- Dallas, TX27 studier
- Boston, MA26 studier
- Washington, DC26 studier
- Los Angeles, CA24 studier
- Baltimore, MD24 studier
- St. Louis, MO22 studier
- Philadelphia, PA21 studier
- Seattle, WA21 studier
- Edison, NJ21 studier
Andre studier i Rochester
- Brystkræft42 studier
- Ikke-småcellet lungecancer37 studier
- Metastatisk cancer31 studier
- Kræft (alle typer)30 studier
- Colorektal kræft29 studier
- Ægstockræft29 studier
- Multipelt myelom24 studier
- Prostatakræft22 studier
- Hjertesvigt22 studier
- Bugspytkirtelkræft22 studier
- Lungecancer20 studier
- Livmoderslimhindekræft20 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.